Literature DB >> 19334711

Design, synthesis, and evaluation of an alpha-helix mimetic library targeting protein-protein interactions.

Alex Shaginian1, Landon R Whitby, Sukwon Hong, Inkyu Hwang, Bilal Farooqi, Mark Searcey, Jiandong Chen, Peter K Vogt, Dale L Boger.   

Abstract

The design and solution-phase synthesis of an alpha-helix mimetic library as an integral component of a small-molecule library targeting protein-protein interactions are described. The iterative design, synthesis, and evaluation of the candidate alpha-helix mimetic was initiated from a precedented triaryl template and refined by screening the designs for inhibition of MDM2/p53 binding. Upon identifying a chemically and biologically satisfactory design and consistent with the screening capabilities of academic collaborators, the corresponding complete library was assembled as 400 mixtures of 20 compounds (20 x 20 x 20-mix), where the added subunits are designed to mimic all possible permutations of the naturally occurring i, i + 4, i + 7 amino acid side chains of an alpha-helix. The library (8000 compounds) was prepared using a solution-phase synthetic protocol enlisting acid/base liquid-liquid extractions for purification on a scale that insures its long-term availability for screening campaigns. Screening of the library for inhibition of MDM2/p53 binding not only identified the lead alpha-helix mimetic upon which the library was based, but also suggests that a digestion of the initial screening results that accompany the use of such a comprehensive library can provide insights into the nature of the interaction (e.g., an alpha-helix mediated protein-protein interaction) and define the key residues and their characteristics responsible for recognition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19334711      PMCID: PMC2765553          DOI: 10.1021/ja810025g

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  73 in total

1.  Proteinminus signProtein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis.

Authors:  Wesley E. Stites
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

2.  Solution-phase parallel synthesis of a pharmacophore library of HUN-7293 analogues: a general chemical mutagenesis approach to defining structure-function properties of naturally occurring cyclic (depsi)peptides.

Authors:  Yan Chen; Melitta Bilban; Carolyn A Foster; Dale L Boger
Journal:  J Am Chem Soc       Date:  2002-05-15       Impact factor: 15.419

3.  Design and application of an alpha-helix-mimetic scaffold based on an oligoamide-foldamer strategy: antagonism of the Bak BH3/Bcl-xL complex.

Authors:  Justin T Ernst; Jorge Becerril; Hyung Soon Park; Hang Yin; Andrew D Hamilton
Journal:  Angew Chem Int Ed Engl       Date:  2003-02-03       Impact factor: 15.336

Review 4.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

5.  Chimeric (alpha/beta + alpha)-peptide ligands for the BH3-recognition cleft of Bcl-XL: critical role of the molecular scaffold in protein surface recognition.

Authors:  Jack D Sadowsky; Margaret A Schmitt; Hee-Seung Lee; Naoki Umezawa; Shaomeng Wang; York Tomita; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2005-08-31       Impact factor: 15.419

6.  Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo.

Authors:  Holly K Koblish; Shuyuan Zhao; Carol F Franks; Robert R Donatelli; Rose M Tominovich; Louis V LaFrance; Kristi A Leonard; Joan M Gushue; Daniel J Parks; Raul R Calvo; Karen L Milkiewicz; Juan José Marugán; Pierre Raboisson; Maxwell D Cummings; Bruce L Grasberger; Dana L Johnson; Tianbao Lu; Christopher J Molloy; Anna C Maroney
Journal:  Mol Cancer Ther       Date:  2006-01       Impact factor: 6.261

7.  Synthesis of alpha-helix mimetics with four side-chains.

Authors:  Per Restorp; Julius Rebek
Journal:  Bioorg Med Chem Lett       Date:  2008-06-28       Impact factor: 2.823

Review 8.  Towards protein surface mimetics.

Authors:  D P Fairlie; M L West; A K Wong
Journal:  Curr Med Chem       Date:  1998-02       Impact factor: 4.530

9.  Structure-based design, synthesis, and biological evaluation of novel 1,4-diazepines as HDM2 antagonists.

Authors:  Pierre Raboisson; Juan José Marugán; Carsten Schubert; Holly K Koblish; Tianbao Lu; Shuyuan Zhao; Mark R Player; Anna C Maroney; Rolanda L Reed; Norman D Huebert; Jennifer Lattanze; Daniel J Parks; Maxwell D Cummings
Journal:  Bioorg Med Chem Lett       Date:  2005-04-01       Impact factor: 2.823

10.  Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models.

Authors:  Anna L Bowman; Zaneta Nikolovska-Coleska; Haizhen Zhong; Shaomeng Wang; Heather A Carlson
Journal:  J Am Chem Soc       Date:  2007-09-29       Impact factor: 15.419

View more
  51 in total

Review 1.  Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009.

Authors:  Roland E Dolle; Bertrand Le Bourdonnec; Karin Worm; Guillermo A Morales; Craig J Thomas; Wei Zhang
Journal:  J Comb Chem       Date:  2010-10-05

2.  Extending foldamer design beyond α-helix mimicry: α/β-peptide inhibitors of vascular endothelial growth factor signaling.

Authors:  Holly S Haase; Kimberly J Peterson-Kaufman; Sheeny K Lan Levengood; James W Checco; William L Murphy; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2012-05-01       Impact factor: 15.419

3.  Universal peptidomimetics.

Authors:  Eunhwa Ko; Jing Liu; Lisa M Perez; Genliang Lu; Amber Schaefer; Kevin Burgess
Journal:  J Am Chem Soc       Date:  2010-12-23       Impact factor: 15.419

4.  Evaluating minimalist mimics by exploring key orientations on secondary structures (EKOS).

Authors:  Dongyue Xin; Eunhwa Ko; Lisa M Perez; Thomas R Ioerger; Kevin Burgess
Journal:  Org Biomol Chem       Date:  2013-10-14       Impact factor: 3.876

5.  Potential pharmacological chaperones targeting cancer-associated MCL-1 and Parkinson disease-associated α-synuclein.

Authors:  Misook Oh; Ji Hoon Lee; Wei Wang; Hui Sun Lee; Woo Sirl Lee; Christopher Burlak; Wonpil Im; Quyen Q Hoang; Hyun-Suk Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

6.  Discovery of HIV fusion inhibitors targeting gp41 using a comprehensive α-helix mimetic library.

Authors:  Landon R Whitby; Kristopher E Boyle; Lifeng Cai; Xiaoqian Yu; Miriam Gochin; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2012-03-03       Impact factor: 2.823

Review 7.  Inhibition of α-helix-mediated protein-protein interactions using designed molecules.

Authors:  Valeria Azzarito; Kérya Long; Natasha S Murphy; Andrew J Wilson
Journal:  Nat Chem       Date:  2013-03       Impact factor: 24.427

8.  Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists.

Authors:  Matthew D Morin; Ying Wang; Brian T Jones; Yuto Mifune; Lijing Su; Hexin Shi; Eva Marie Y Moresco; Hong Zhang; Bruce Beutler; Dale L Boger
Journal:  J Am Chem Soc       Date:  2018-10-16       Impact factor: 15.419

9.  A peptidomimetic approach to targeting pre-amyloidogenic states in type II diabetes.

Authors:  James A Hebda; Ishu Saraogi; Mazin Magzoub; Andrew D Hamilton; Andrew D Miranker
Journal:  Chem Biol       Date:  2009-09-25

10.  Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer.

Authors:  Preethi Ravindranathan; Tae-Kyung Lee; Lin Yang; Margaret M Centenera; Lisa Butler; Wayne D Tilley; Jer-Tsong Hsieh; Jung-Mo Ahn; Ganesh V Raj
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.